VALENTE, SERAFINA
 Distribuzione geografica
Continente #
NA - Nord America 13.137
EU - Europa 10.499
AS - Asia 6.539
SA - Sud America 1.469
Continente sconosciuto - Info sul continente non disponibili 756
AF - Africa 412
OC - Oceania 11
Totale 32.823
Nazione #
US - Stati Uniti d'America 12.823
IT - Italia 4.161
RU - Federazione Russa 2.410
SG - Singapore 2.078
CN - Cina 1.495
BR - Brasile 1.217
IE - Irlanda 840
VN - Vietnam 820
GB - Regno Unito 761
HK - Hong Kong 566
DE - Germania 533
FR - Francia 437
BD - Bangladesh 408
KR - Corea 381
FI - Finlandia 338
SE - Svezia 310
IN - India 244
NL - Olanda 226
ZA - Sudafrica 217
CA - Canada 169
ES - Italia 91
MX - Messico 85
AR - Argentina 78
PL - Polonia 71
IQ - Iraq 64
JP - Giappone 62
ID - Indonesia 60
UA - Ucraina 59
AT - Austria 56
EC - Ecuador 46
TR - Turchia 44
KE - Kenya 42
CZ - Repubblica Ceca 38
CI - Costa d'Avorio 37
IR - Iran 35
VE - Venezuela 35
CH - Svizzera 33
PH - Filippine 32
PK - Pakistan 32
UZ - Uzbekistan 31
MA - Marocco 28
SA - Arabia Saudita 28
CO - Colombia 24
CL - Cile 23
PE - Perù 20
EG - Egitto 19
MY - Malesia 19
LT - Lituania 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
BE - Belgio 17
NG - Nigeria 17
AL - Albania 16
DZ - Algeria 15
AZ - Azerbaigian 13
JO - Giordania 13
TN - Tunisia 13
NP - Nepal 11
TW - Taiwan 10
AU - Australia 9
JM - Giamaica 9
BG - Bulgaria 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
KZ - Kazakistan 8
CY - Cipro 7
GT - Guatemala 7
IL - Israele 7
LV - Lettonia 7
RO - Romania 7
GR - Grecia 6
MK - Macedonia 6
QA - Qatar 6
TH - Thailandia 6
UY - Uruguay 6
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
KG - Kirghizistan 5
NI - Nicaragua 5
NO - Norvegia 5
OM - Oman 5
PA - Panama 5
SV - El Salvador 5
AO - Angola 4
BB - Barbados 4
BY - Bielorussia 4
GE - Georgia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BW - Botswana 3
CR - Costa Rica 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
Totale 32.027
Città #
Dallas 6.216
Singapore 1.276
Milan 869
Dublin 799
Moscow 757
Ashburn 702
San Jose 631
Hefei 556
Santa Clara 530
Hong Kong 529
Southend 508
Council Bluffs 504
Seoul 377
Rome 365
Chandler 311
Los Angeles 307
Siena 307
Beijing 278
Munich 278
Ho Chi Minh City 277
New York 242
Florence 217
Helsinki 215
Johannesburg 199
Fairfield 180
Hanoi 177
Lauterbourg 177
The Dalles 142
São Paulo 125
Buffalo 115
Houston 98
Seattle 96
Princeton 95
Bengaluru 84
Chicago 82
Naples 79
Nuremberg 77
Orem 71
Columbus 70
Shanghai 70
Bologna 69
Woodbridge 69
Turin 65
Cambridge 64
Wilmington 60
Ann Arbor 59
Redondo Beach 57
Turku 57
Warsaw 55
London 54
Tokyo 54
Lappeenranta 53
Figino 52
Toronto 50
Frankfurt am Main 49
Montreal 47
Rio de Janeiro 47
Dong Ket 43
Brescia 42
Guangzhou 39
Abidjan 37
Denver 37
Haiphong 37
Phoenix 36
Brooklyn 35
Málaga 35
Atlanta 33
Mexico City 33
Baghdad 32
Chennai 31
Poplar 31
San Diego 30
Piscataway 29
Amsterdam 28
Boardman 28
Boston 28
Da Nang 28
Fremont 28
Mumbai 28
Stockholm 28
Tashkent 27
Portsmouth 26
Charlotte 25
Genoa 24
Vienna 24
Washington 23
Catania 22
Düsseldorf 22
Manchester 22
San Mateo 22
Zurich 22
Biên Hòa 21
Palermo 21
Salt Lake City 21
Newark 20
Brasília 19
Salvador 19
Verona 19
Bari 18
Brno 18
Totale 21.140
Nome #
Vo2peak, Ve/VCO2, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients 1.283
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect in Athletes: A Study With a Long-Term Follow-Up 850
Antiplatelet and Anticoagulation Therapy in Athletes: A Cautious Compromise… If Possible! 658
A first update on mapping the human genetic architecture of COVID-19 601
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 592
Il test da sforzo cardiopolmonare: uno strumento fondamentale per una prescrizione personalizzata dell’esercizio fisico nei pazienti con malattia cardiovascolare : Cardiopulmonary exercise testing: an essential tool for a tailored exercise prescription in patients with cardiac disease 570
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 534
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 508
Prognostic value of left atrial strain in acute and chronic heart failure: A meta-analysis 502
Genetic mechanisms of critical illness in COVID-19 451
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 440
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction 438
Pressure-strain loops unveil haemodynamics behind mechanical circulatory support systems 422
An explainable model of host genetic interactions linked to COVID-19 severity 386
Pathogen-sugar interactions revealed by universal saturation transfer analysis 373
Antirheumatic agents in covid-19: is IL-6 the right target? 368
The loss of left atrial contractile function predicts a worse outcome in HFrEF patients 360
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 355
The role of cardiac computed tomography in sports cardiology: back to the future! 334
Mapping the human genetic architecture of COVID-19 325
Peripheral biomarkers' panel for severe COVID-19 patients 323
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 319
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 313
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 309
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 302
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 284
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 260
Prognostic bioindicators in severe COVID-19 patients 258
The importance of ventilatory thresholds to define aerobic exercise intensity in cardiac patients and healthy subjects 257
Serial KL-6 measurements in COVID-19 patients 253
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 248
Clinician approach to cardiopulmonary exercise testing for exercise prescription in patients at risk of and with cardiovascular disease 247
Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation 244
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young 239
A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play 238
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge 232
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 231
Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective? 230
Bedside Ultrasound for Hemodynamic Monitoring in Cardiac Intensive Care Unit 229
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 229
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide 228
SARS-CoV-2 in pleural fluid in a kidney transplant patient 223
Detection of cardiac allograft vasculopathy by multi-layer left ventricular longitudinal strain in heart transplant recipients 221
Whole-genome sequencing reveals host factors underlying critical COVID-19 217
ACUTE HF score: a new multi-parametric score for the prognostication of acute heart failure 215
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 215
Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement 209
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up 206
Aortic root/left ventricular diameters golden ratio in competitive athletes 206
Clinical and molecular characterization of COVID-19 hospitalized patients 206
Cardiogenic shock and acute kidney injury: the rule rather than the exception 205
Clinical management of young competitive athletes with premature ventricular beats: A prospective cohort study 204
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 202
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 202
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 201
Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study 199
Survival in acute heart failure in intensive cardiac care unit: a prospective study 198
Right ventricular myocardial work for the prediction of early right heart failure and long-term mortality after left ventricular assist device implant 197
Basic and advanced echocardiography in advanced heart failure: an overview 195
Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation 191
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab 189
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 186
SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? 186
Correlation of Left Ventricular Myocardial Work Indices with Invasive Measurement of Stroke Work in Patients with Advanced Heart Failure 185
How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation 185
Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition 185
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy 184
Clinical profile and management of patients with acute myocardial infarction admitted to cardiac care units: The EYESHOT-2 registry 181
Left ventricular fibrosis as a main determinant of filling pressures and left atrial function in advanced heart failure 181
Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool 173
Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome 170
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 169
Left ventricular assist device in cardiac amyloidosis: friend or foe? 168
Diastolic function in heart transplant: From physiology to echocardiographic assessment and prognosis 166
Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value 165
COVID-19 and the burning issue of drug interaction: Never forget the ECG 160
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning 159
Post-acute sequelae of COVID-19: the potential role of exercise therapy in treating patients and athletes returning to play 158
Clinical pathway for cardiogenic shock. A proposal from ANMCO Tuscany [Clinical pathway per lo shock cardiogeno. La proposta dell’ANMCO Toscana] 158
Left ventricular assist device and transcatheter edge-to-edge mitral valve repair in advanced heart failure: allies or enemies? 158
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences 157
Safe performance of echocardiography during the COVID-19 pandemic: A practical guide 152
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications 149
Risk stratification in cardiogenic shock: a focus on the available evidence 149
Zero-fluoroscopy catheter ablation of premature ventricular contractions at left coronary cusp near left main coronary artery 148
ANMCO Position Paper: Amyloidosis for the clinical cardiologist. A "clinical primer" from the ANMCO Rare Disease Working Group [Position paper ANMCO: L’amiloidosi per il cardiologo clinico. Un “clinical primer” dell’Area Malattie Rare ANMCO] 147
Low HDL cholesterol and the eNOS Glu298Asp polymorphism are associated with inducible myocardial ischemia in patients with suspected stable coronary artery disease 147
ANMCO Position paper: Antithrombotic treatment of patients with atrial fibrillation and acute or chronic coronary syndromes undergoing coronary angioplasty with stent implantation [Position paper ANMCO: Trattamento antitrombotico nei pazienti con fibrillazione atriale e sindromi coronariche acute o croniche sottoposti ad angioplastica coronarica con impianto di stent] 147
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 147
Non-invasive assessment of acute heart failure by Stevenson classification: Does echocardiographic examination recognize different phenotypes? 144
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients 144
ANMCO Position Paper: Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation 143
Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine 143
Acute coronary syndromes during COVID-19 142
Pulmonary artery catheter in cardiac intensive care 141
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes 139
From Coronary Artery Ectasia to Giant Coronary Artery Aneurysm: Is it Necessary to Follow-Up? 137
Myocardial Work Indices Predict Hospitalization in Patients with Advanced Heart Failure 136
ANMCO Position paper: Gender differences in the cardiovascular pharmacological approach [Position paper ANMCO: Differenze di genere nell’approccio farmacologico cardiovascolare] 135
Hemodynamic variations and pitfalls during venoarterial extracorporeal membrane oxygenation and left ventricular apical unloading as bridge to heart transplantation 135
Totale 26.083
Categoria #
all - tutte 92.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.121 0 96 72 68 64 81 122 80 57 103 144 234
2022/20231.517 88 139 178 136 98 220 130 137 92 83 88 128
2023/20242.045 93 88 204 172 104 363 561 96 40 79 67 178
2024/20255.896 167 188 468 265 499 687 531 366 516 312 543 1.354
2025/202619.902 924 4.187 3.860 2.069 2.799 582 1.553 478 600 915 784 1.151
2026/20271.213 797 416 0 0 0 0 0 0 0 0 0 0
Totale 32.823